View in EDS

NY-ESO-1 and PD-L1 as biomarkers associated with nivolumab response and outcome in unresectable or recurrent esophageal squamous cell carcinoma: a multicenter biomarker study.

Saved in:
Bibliographic Details
Title: NY-ESO-1 and PD-L1 as biomarkers associated with nivolumab response and outcome in unresectable or recurrent esophageal squamous cell carcinoma: a multicenter biomarker study.
Authors: Nakai S; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan., Makino T; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan. tmakino@gesurg.med.osaka-u.ac.jp., Momose K; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan., Yamashita K; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan., Tanaka K; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan., Miyata H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Yamamoto S; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan., Motoori M; Department of Surgery, Osaka General Medical Center, Osaka, Japan., Kimura Y; Department of Gastroenterological Surgery, Kindai University Nara Hospital, Nara, Japan., Takeoka T; Department of Surgery, Sakai City Medical Center, Osaka, Japan., Hirao M; Department of Surgery, NHO Osaka National Hospital, Osaka, Japan., Matsuyama J; Department of Gastroenterological Surgery, Higashiosaka City Medical Center, Osaka, Japan., Akamaru Y; Department of Surgery, Osaka Rosai Hospital, Osaka, Japan., Kurokawa Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan., Morii E; Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan., Eguchi H; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan., Doki Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 May 12. Date of Electronic Publication: 2026 May 12.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42118259
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: NY-ESO-1 and PD-L1 as biomarkers associated with nivolumab response and outcome in unresectable or recurrent esophageal squamous cell carcinoma: a multicenter biomarker study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nakai+S%22">Nakai S</searchLink>; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan.<br /><searchLink fieldCode="AU" term="%22Makino+T%22">Makino T</searchLink>; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan. tmakino@gesurg.med.osaka-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Momose+K%22">Momose K</searchLink>; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan.<br /><searchLink fieldCode="AU" term="%22Yamashita+K%22">Yamashita K</searchLink>; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan.<br /><searchLink fieldCode="AU" term="%22Tanaka+K%22">Tanaka K</searchLink>; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan.<br /><searchLink fieldCode="AU" term="%22Miyata+H%22">Miyata H</searchLink>; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+S%22">Yamamoto S</searchLink>; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Motoori+M%22">Motoori M</searchLink>; Department of Surgery, Osaka General Medical Center, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kimura+Y%22">Kimura Y</searchLink>; Department of Gastroenterological Surgery, Kindai University Nara Hospital, Nara, Japan.<br /><searchLink fieldCode="AU" term="%22Takeoka+T%22">Takeoka T</searchLink>; Department of Surgery, Sakai City Medical Center, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Hirao+M%22">Hirao M</searchLink>; Department of Surgery, NHO Osaka National Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Matsuyama+J%22">Matsuyama J</searchLink>; Department of Gastroenterological Surgery, Higashiosaka City Medical Center, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Akamaru+Y%22">Akamaru Y</searchLink>; Department of Surgery, Osaka Rosai Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kurokawa+Y%22">Kurokawa Y</searchLink>; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan.<br /><searchLink fieldCode="AU" term="%22Morii+E%22">Morii E</searchLink>; Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Eguchi+H%22">Eguchi H</searchLink>; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan.<br /><searchLink fieldCode="AU" term="%22Doki+Y%22">Doki Y</searchLink>; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2026 May 12. <i>Date of Electronic Publication: </i>2026 May 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42118259
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00262-026-04415-x
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: NY-ESO-1 and PD-L1 as biomarkers associated with nivolumab response and outcome in unresectable or recurrent esophageal squamous cell carcinoma: a multicenter biomarker study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nakai S
      – PersonEntity:
          Name:
            NameFull: Makino T
      – PersonEntity:
          Name:
            NameFull: Momose K
      – PersonEntity:
          Name:
            NameFull: Yamashita K
      – PersonEntity:
          Name:
            NameFull: Tanaka K
      – PersonEntity:
          Name:
            NameFull: Miyata H
      – PersonEntity:
          Name:
            NameFull: Yamamoto S
      – PersonEntity:
          Name:
            NameFull: Motoori M
      – PersonEntity:
          Name:
            NameFull: Kimura Y
      – PersonEntity:
          Name:
            NameFull: Takeoka T
      – PersonEntity:
          Name:
            NameFull: Hirao M
      – PersonEntity:
          Name:
            NameFull: Matsuyama J
      – PersonEntity:
          Name:
            NameFull: Akamaru Y
      – PersonEntity:
          Name:
            NameFull: Kurokawa Y
      – PersonEntity:
          Name:
            NameFull: Morii E
      – PersonEntity:
          Name:
            NameFull: Eguchi H
      – PersonEntity:
          Name:
            NameFull: Doki Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 05
              Text: 2026 May 12
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0851
          Titles:
            – TitleFull: Cancer immunology, immunotherapy : CII
              Type: main
ResultId 1